Novonix (NVX) Receivables (2020 - 2025)

Novonix (NVX) has reported Receivables for 6 consecutive years, with $2.9 million the latest figure, recorded in Q4 2025.

• Quarterly Receivables fell 66.63% year-over-year to $2.9 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $2.9 million (down 66.63% YoY) and the FY2025 annual result came in at $7.2 million, down 28.91% from the prior year.
• Receivables declined to $2.9 million in Q4 2025 per NVX's latest filing, from $18.9 million in the prior quarter.
• Over the last five years, Receivables for NVX reached as high as $18.9 million in Q2 2025 and fell as low as $1.8 million in Q2 2021.
• A 5-year average of $5.0 million and a median of $2.9 million in 2025 frame the typical range for Receivables.
• The largest YoY upside for Receivables was 649.62% in 2025 against a maximum downside of 66.63% in 2025.
• Year by year, Receivables stood at $2.5 million in 2021, then jumped by 34.8% to $3.4 million in 2022, then climbed by 21.58% to $4.1 million in 2023, then jumped by 110.51% to $8.6 million in 2024, then slumped by 66.63% to $2.9 million in 2025.
• According to Business Quant data, Receivables over the past three periods registered $2.9 million, $18.9 million, and $8.6 million for Q4 2025, Q2 2025, and Q4 2024 respectively.